IgG4-related autoimmune manifestations in Alemtuzumab-treated multiple sclerosis patients

AG Vakrakou, D Tzanetakos… - Journal of …, 2021 - Elsevier
We aimed to determine whether Alemtuzumab-induced immune reconstitution affects
immunoglobulin and complement levels in the serum of Relapsing-Remitting Multiple …
被引用次数：4 相关文章

IgG4-related autoimmune manifestations in Alemtuzumab-treated multiple sclerosis patients

AG Vakrakou, D Tzanetakos… - Journal of …, 2021 - jni-journal.com
We aimed to determine whether Alemtuzumab-induced immune reconstitution affects
immunoglobulin and complement levels in the serum of Relapsing-Remitting Multiple …

IgG4-related autoimmune manifestations in Alemtuzumab-treated multiple sclerosis patients

AG Vakrakou, D Tzanetakos… - Journal of …, 2021 - pubmed.ncbi.nlm.nih.gov
We aimed to determine whether Alemtuzumab-induced immune reconstitution affects
immunoglobulin and complement levels in the serum of Relapsing-Remitting Multiple …

IgG4-related autoimmune manifestations in Alemtuzumab-treated multiple sclerosis patients.

AG Vakrakou, D Tzanetakos… - Journal of …, 2021 - europepmc.org
We aimed to determine whether Alemtuzumab-induced immune reconstitution affects
immunoglobulin and complement levels in the serum of Relapsing-Remitting Multiple …

IgG4-related autoimmune manifestations in Alemtuzumab-treated multiple sclerosis patients

AG Vakrakou, D Tzanetakos… - Journal of …, 2021 - jni-journal.com
We aimed to determine whether Alemtuzumab-induced immune reconstitution affects
immunoglobulin and complement levels in the serum of Relapsing-Remitting Multiple …